Insuficiência cardíaca com fração de ejeção preservada: diagnóstico
Drechsler, Carine Elisabete Rost; Danzmann, Luiz Cláudio.
Acta méd. (Porto Alegre)
; 30: 571-581, 2009.
Artigo em Português | LILACS | ID: lil-546769
[Modern pharmacotherapy in heart failure with reduced ejection fraction: is further improvement in prognosis possible?].
[The Evaluation of Left Ventricular Diastolic Function by Echocardiography in Patients With Preserved Ejection Fraction].
[Pressure and Volume Characteristics of the Left VentriclÐµ in Its Diastolic and Systolic Dysfunction].
The Nitrate-Nitrite-NO Pathway as a Novel Therapeutic Target in Heart Failure with Reduced Ejection Fraction.
Detection of interventricular dyssynchrony: An evolution of the phase analysis technique.
Can serial changes of diastolic dysfunction signal incremental risk of chemotherapy-induced heart failure missed by the timing of declining LV ejection fraction?
Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.
Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction.
Ecocardiografia com strain para avaliação de pacientes com disfunção diastólica e fração de ejeção preservada: estamos prontos?
Heart failure with mid-range ejection fraction: are there clinical reasons in introduction of this new group as a distinct entity?